U.S. to resume J&J COVID vaccinations despite rare clot risk
The U.S. decision—similar to how European regulators are rolling out J&J’s shot—comes after CDC advisers earlier Friday voted 10-4 to resume vaccinations but panelists made clear that they must come with warnings about the risk.